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ABSTRACT
Purpose: To compare the size of the coagulation (CZ) and periablational (PZ) zones created with two
commercially available devices in clinical use for radiofrequency (RFA) and microwave ablation (MWA),
respectively.
Methods: Computer models were used to simulate RFA with a 3-cm Cool-tip applicator and MWA
with an Amica-Gen applicator. The Arrhenius model was used to compute the damage index (X). CZ
was considered when X> 4.6 (>99% of damaged cells). Regions with 0.6<X< 2.1 were considered as
the PZ (tissue that has undergone moderate sub-ablative hyperthermia). The ratio of PZ volume to CZ
volume (PZ/CZ) was regarded as a measure of performance, since a low value implies achieving a
large CZ while keeping the PZ small.
Results: Ten-min RFA (51W) created smaller periablational zones than 10-min MWA (11.3 cm3 vs.
17.222.9 cm3, for 60100W MWA, respectively). Prolonging duration from 5 to 10min increased the
PZ in MWA more than in RFA (2.7 cm3 for RFA vs. 8.311.9 cm3 for 60100W MWA, respectively).
PZ/CZ for RFA were relatively high (6569%), regardless of ablation time, while those for MWA were
highly dependent on the duration (increase of up to 25% between 5 and 10min) and on the applied
power (smaller values as power was raised, 102% for 60W vs. 81% for 100W, both for 10min). The
lowest PZ/CZ across all settings was 56%, obtained with 100W-5min MWA.
Conclusions: Although RFA creates smaller periablational zones than MWA, 100W-5min MWA pro-
vides the lowest PZ/CZ.
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1. Introduction
Energy-based high-temperature ablative therapies such as
radiofrequency ablation (RFA) or microwave ablation (MWA)
have demonstrated their ability to thermally destroy tumors
by creating a coagulation zone that covers a 0.51 cm safety
margin around the entire tumor. However, evidence is now
emerging that any tumor regions that do not reach ablative
temperatures may be subsequent promoters of tumor
growth [1]. This area, called the periablational zone, is always
present around the coagulation zone (Figure 1(a)). Even
when a previously identified tumor is completely destroyed,
the presence of (previously unidentified) satellite micronod-
ules in its vicinity involves a risk when only subjected to
moderate heating, i.e., when the micronodules are inside the
periablational zone (Figure 1(a)). The ideal ablative technique
therefore should be able to create a coagulation zone
around the entire tumor plus a 0.5–1 cm margin while
keeping the periablational zone beyond the margin as small
as possible. The ratio of periablational zone volume to
coagulation zone volume could be considered as a measure
of value, since an ideal ablative technique should be able to
create a large coagulation zone while keeping the periabla-
tional zone as small as possible, i.e., the best technique is
the one with the lowest PZ/CZ ratio.
Several published studies have compared the outcomes
following RFA and MWA. Bench tests [2–5], pre-clinical [6,7]
and clinical studies [6] have compared coagulation zone size
and treatment outcomes after both energy modalities. While
some recent pre-clinical and clinical studies have compared
the pro-tumorigenic effects of RFA and MWA [8–10], only
one recent ex vivo study indirectly compared the volume of
the RFA/MWA transition zone, its relationship with residual
thermal energy after ablation, and the effect of subsequent
cooling on reducing the transition zone [11].
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There remains a gap in our knowledge of the size of the
periablational zone after thermal ablation in general and the
comparative extent of the periablational zone after RFA and
MWA. Computer models were thus used to study the ther-
mal performance of two commercial devices widely used for
radiofrequency (RFA) and microwave ablation (MWA),
respectively, and to compare the size of the periablational
zones created by each device.
2. Methods
2.1. Modeling of periablational and coagulation zones
Computer modeling is widely used to evaluate specific issues
of energy-based ablative techniques. Both the physical equa-
tions on which they are based and the mathematical frame-
work used to obtain the solutions are now well established
and many of them have been validated in terms of coagula-
tion zone size. This size can be estimated by the Arrhenius
damage model, which associates temperature with exposure
time by a first-order kinetics relationship [12]. This model
provides a damage index X which is related to the percent-
age of living cells after the tissue has undergone heating. As
X> 4.6 means that more than 99% of the cells have been
irreversibly destroyed (see Figure 1(b)), the X¼ 4.6 contour is
often used to compute the size of the coagulation zone.
As yet, no thresholds have been established for assessing
the extent of the periablational zone based on X. However,
although there is still no accurate assessment of the scope of
this entire area, there do exist experimental data that provide
some insight on the subject and may be used as a guide in
selecting suitable thresholds; for example, the study by
Markezana et al. [1] reports a statistically significant acceler-
ated growth of tumor cells subjected to moderate hyperther-
mia, especially when heated to 43 and 45 C for 5 and 10min.
We used these four combinations of temperature time val-
ues to estimate the range of X to define the periablational
zone by means of the Arrhenius damage model with the fol-
lowing parameters: frequency factor A¼ 7.39 1039 s1 and
activation energy DE ¼ 2.577 105 J/mol [13]. We determined
that the periablational zone could be limited to between
X¼ 0.6 and X¼ 2.1 (see Figure 1(b)). As 55% of cells are still
viable at a damage index of X¼ 0.6 and 12% at X¼ 2.1, this
means that the periablational zone includes both viable cells
and those damaged by heating, which can range from around
55% at X¼ 0.6 to 88% at X¼ 2.1. It must be recognized that
the entire periablational zone is composed of cells subjected
to moderate hyperthermic heating and is not necessarily lim-
ited to the thermal doses considered by Markezana et al. [1],
and that if different X values were to be found in future stud-
ies this would mean redefining the periablational zone and
changing some of the conclusions.
2.2. Modeling MWA and RFA applicators
The RFA and MWA models were based on those described in
[14] and [15]. The geometry of both models was comprised
of an applicator (RF electrode or MW antenna) surrounded
by a cylinder of liver tissue. For RFA we modeled a Cool-tip
applicator (Covidien, Boulder, CO, USA), which is a conven-
tionally cooled, needlelike, 1.5mm diameter 17G electrode
with a 3 cm active tip, as described in [14]. For MWA we
modeled a 20mm long, 14G applicator equipped with a
mini-choke which mimicked the HS Amica-Gen device (HS
AMICA PROBE, HS Hospital Service, Aprilia, Italy) described in
[15]. As the geometries presented axial symmetry a two-
dimensional analysis was possible.
Both models solved a thermal problem coupled with an
electrical (RFA) or electromagnetic (MWA) problem. To solve
the thermal problem we used the Bioheat equation modified
by the enthalpy method to take vaporization into account
and ignored the metabolic heat, which is negligible in both
RFA and MWA. The governing equation for the thermal prob-
lem was therefore:
oðqhÞ
ot
¼ r  ðkrTÞ þ qþ Qp (1)
where q (kg/m3) is tissue density, h (J/kgK) enthalpy, k
(W/mK) thermal conductivity, T (C) temperature, t (s) time,
q the heat source and Qp heat loss by blood perfusion. For
Figure 1. (a) Moderate hyperthermic heating occurs in periablational zone and has been related with tumor cell activity [1]. This heating could affect either a
tumor area outside the thermal coagulation zone (which is completely destroyed) or nearby micronodules. (b) Relation between percentage of living cells after
heating and index X obtained from the Arrhenius damage model, which associates temperature with exposure time using a first-order kinetics relationship.
Periablational zone was assumed to be between X¼ 0.6 and X¼ 2.1 (values derived from experimental data in [1], see text for details), while coagulation zone
was defined by the X¼ 4.6 contour, which represents 99% probability of cell death.
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biological tissues enthalpy is related to tissue temperature
by the following expression [16]:
oðqhÞ
ot
¼ oT
ot

( qlcl 0<T  99C
hfgC 99<T  100C
qgcg T>100
C
(2)
where qi and ci are density and specific heat of tissue
respectively at temperatures below 100 C (i¼ l) and at tem-
peratures above 100 C (i¼ g), hfg is the product of water
latent heat of vaporization and water density at 100 C, and
C is tissue water content inside the liver (68%) [17].
In both the RFA and MWA models q represented the time
average power absorption. In the MWA model q was com-
puted from the distribution of the electrical field vector ~E(V/
m) as follows:
q ¼ 1
2
rej~Ej2 (3)
where re (S/m) is the (effective) conductivity at 2.45GHz and
j~Ej is the Euclidean norm of ~E (where the x, y, and z compo-
nents of this vector are peak values). The distribution of ~E
was calculated by solving Maxwell’s equations. In contrast,
quasi-static approximation was used in the RFA model, which
involved replacing all the RF electrical variables (including ~E)
by DC variables with the same value as the root-mean-
square value of the RF signals. q was therefore computed as
follows:
q ¼ rj~Ej2 (4)
where r is the conductivity at 500 kHz and j~Ej is the
Euclidean norm of ~E (where the x, y, and z components of
this vector are equivalent to the root-mean-square value of
the RF signal). The electrical field vector was obtained from
~E ¼ rV , V being the voltage, which was obtained from
the governing equation r(r(T)rV)¼0.
The blood perfusion term Qp was obtained from
Qp ¼ bqbcbxbðTbTÞ (5)
where xb is the blood perfusion coefficient (0.019 s
1), qb
and cb are the blood density and specific heat, respectively,
Tb is the temperature of the arterial blood (37 C) and b is a
coefficient that modifies blood perfusion with tissue damage:
b¼ 0 for X 4.6, and b¼ 1 for X< 4.6.
Both models (RFA and MWA) included the same tissue
type with the characteristics described in [14]. Table 1 sum-
marizes the characteristics of all the materials in the model
[14,15,18–20]. The changes in the tissue electrical properties
were modeled using the equations proposed in [14] for RFA:
r Tð Þ ¼
0:19 e0:015ðT37Þ 0  T < 99C
0:192:5345 99  T  100C
0:192:53430:50183 T  100ð Þ 100 < T < 105C
0:192:5345102 T > 105C
8><
>:
(6)
and in [15] for MWA:
erðTÞ ¼ 44:3 1 11þ e5:2230:524T
 
(7)
re Tð Þ ¼ 1:8 1 11þ e6:5830:598T
 
(8)
Null flux was set as a boundary condition in the symmetry
axis for the thermal, electrical and electromagnetic problems.
A constant temperature of 37 C (same as the initial) was set
at the rest of the boundaries for the thermal problem. The
RF electrode’s cooling effect was modeled by Newton’s law
of cooling using a thermal convection coefficient of 3127W/
Km2 [14] and a coolant temperature of 5 C. The condition
of 0 V was set at the top and bottom boundaries for the RFA
electrical problem to mimic the dispersive electrode and an
electrical insulation condition was set in the remaining
boundary. A first-order electromagnetic scattering boundary
condition was applied in the MWA electromagnetic problem
at the outer boundaries together with an initial electric field
value of 0 V/m.
The MWA input power was specified as a coaxial port
boundary condition at the top of the antenna and in RFA a
constant voltage was set at the electrode boundaries. RFA
was modeled with a typical clinical protocol based on 90 V
pulses, while MWA was modeled with a constant power
protocol of 60, 80 and 100W values, which are typically used
in clinical practice [21,22]. Note that these values are the
power at the applicator input and may not coincide with
those reported in clinical studies in which the reported
power may be the MWA generator output power. We mod-
eled two ablation durations: 5 and 10min. The models were
built and simulated with Comsol Multiphysics software
(COMSOL, Burlington, MA, USA) using a 2D axial symmetry
geometry. The coagulation and periablational zone volumes
were directly calculated by this software by integrating the
2D zones obtained in each simulation across the azimuth
angle. The volumes were computed at two different time
points: immediately after terminating ablation (i.e., at 5 and
10min after the onset of ablation) and 10min after ablation
ended (i.e., 15 and 20min after onset of ablation). The add-
itional growth of the coagulation zone after power is
switched off is due to thermal latency and is especially rele-
vant at very short ablation times [23]. Although we have pre-
viously demonstrated that thermal latency is not significant
in the case of 4min RFA (less than 5% growth in diameter)
[24], the impact of thermal latency after MWA on the abla-
tion and periablational zones has not yet been reported in
the literature.
Table 1. Characteristics of materials used in the computer model
[14,15,18–20].
Material re (S/m) er k (W/mK) q (kg/m3) c (J/kgK) r (S/m)
Liver 1.8(a) 44.3(a) 0.502 1080(b) 3455(b) 0.19(a)
370(c) 2156(c)
Copper 5.87 107 1 385 9000 384
Alumina 0 10 30 3970 875
PTFE 1.6 105 1.8 0.24 1200 1050
Stainless steal 1.74 106 1 16.2 8000 500
Plastic 0.026 70 1045 1 105
Electrode 15 8000 480 7.4 106
re: (effective) conductivity; er: relative permittivity; k: thermal conductivity; q:
density; c: specific heat; r: electrical conductivity.
(a)Measured at 37 C, (b)for temperatures between 37 C and 99 C, (c)for tem-
peratures higher than 100 C.
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Since the ideal ablative technique should be able to cre-
ate a coagulation zone over the entire tumor plus a margin
of healthy tissue while keeping the periablational zone as
small as possible, we compared the ratio of the volumes of
both zones to assess their respective merits.
3. Results
Figure 2 shows the temperature distributions obtained with
RFA vs. MWA (60W) after a 10min ablation and 10min after
switch-off. A similar power level was applied in both cases
(mean RFA power 51W). While the maximum temperature
during RFA was 106 C, this was higher in MWA (142 C at
60W and 152 C at 100W). Both cases presented the typical
coagulation morphology: ellipsoidal in the case of RFA and a
little more spherical in MWA, except for the slight extension
along the applicator shaft toward the connector. The RFA
periablational zone was also ellipsoidal around almost the
entire coagulation zone. The MWA periablational zone sur-
rounded the coagulation zone, although the axial extension
along the applicator shaft was more pronounced than in the
coagulation zone. Figure 2(b) shows the temperature distri-
butions 10min after switch-off. In both cases tissue tempera-
ture had almost returned to the initial value.
Figure 3 shows coagulation and periablational volumes of
all the cases considered. The following coagulation character-
istics were noted: (1) prolonging ablation time from 5 to
10min results in a greater increase in the MWA coagulation
zone (increment of 3.1 cm3 for RFA vs. 6.3, 6.9 and 8.6 cm3
for 60, 80 and 100W MWA, respectively); and (2) both techni-
ques create similar coagulation volumes at similar power lev-
els (16.9 cm3 at 60W constant power vs. 16.3 cm3 at 51W
mean power, both after 10min ablation), while MWA pro-
vides a larger transverse diameter than RFA (3.20 cm vs.
2.56 cm, both after 10min ablation).
The periablational zones in Figure 3 show that: (1) RFA
creates smaller periablational zones than MWA after 10min
ablation and also 10min later (11.3 cm3 vs. 17.2, 19.3 and
22.9 cm3, for 60, 80 and 100W MWA, respectively); and (2) as
with the coagulation zone, prolonging ablation time from 5
Figure 3. Coagulation and periablational zone volumes in RFA/MWA simulations. Lighter color bars and bottom values are the volumes computed just after
switch-off. Darker color bars represent the increase in volume 10min after switch-off. Upper values give total volumes after this 10-min period.
Figure 2. Temperature distributions computed from RFA(Cool-tip applicator, pulsed protocol, 10min) and MWA (Amica-Gen applicator, 60W continuous applica-
tion, 10min) just after switch-off (a) and 10min later (b). White lines represent limits of coagulation zone (X> 4.6) and periablational zones (0.6 < X< 2.1). (Scale
in C; MWA temperatures exceeded 110 C).
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to 10min creates a larger periablational zone in the case of
MWA (increment of 2.7 cm3 for RFA vs. 8.3, 11.9 and 12.0 cm3
for 60, 80 and 100W MWA, respectively).
Figure 4 shows the periablational/coagulation volume
ratios for each energy setting just after switch-off and 10min
later. The findings can be summarized as follows: (1) the RFA
ratios are relatively high (65–69%) regardless of ablation time
(only 4% increase between 5 and 10min); (2) while the MWA
ratio is highly dependent on the duration, with an increase
of 18, 25 and 25% between 5 and 10min at 60, 80 and
100W, respectively; (3) the MWA ratios are also highly
dependent on applied power, with values getting smaller as
power is raised (e.g., 102% for 60W vs. 81% for 100W, both
for 10min); and 4) the lowest ratio was obtained at high-
power short-duration MWA (100W, 5min).
4. Discussion
As no experimental studies have been published to date that
quantify the volume of the periablational zone created by
RFA and MWA procedures, we cannot compare our com-
puter modeling results with experimental data. However,
they can be compared with other commonly reported
experimental parameters such as coagulation diameter and
maximum temperature at points near the applicator. Our
results show that maximum temperatures during MWA
(152 C for 100W and 10min) were significantly higher than
those reached in RFA (106 C for 10min). There are few exist-
ing reports on tissue temperatures during in vivo MWA.
Laeseke et al. [2] measured temperatures of 125 C at
10mm from the antenna after 9min of 90W MWA in in vivo
porcine kidney. Brace et al. [25] measured temperatures
closer to the antenna (5mm) and found values >150 C after
9min of 60W MWA in in vivo porcine kidney. The same stud-
ies reported RFA temperatures limited to <100 C [2,25].
Curto et al. [26] measured temperatures of up to 120 C at
5mm from the antenna at a modest power level (30W) in ex
vivo porcine muscle. Since the temperature gradients next to
the antenna are quite steep, temperatures in the range of
150 C (or even higher) are plausible closer to the antenna.
Most experimental studies simply report coagulation zone
axial and transverse diameters. Some studies calculate the
volume from the values of the diameters, while very few use
the volumetric techniques used in the present study. This
was why our results were compared with previous in vivo
studies in terms of transverse diameters. Table 2 compares
the RFA and MWA coagulation transverse diameters com-
puted after 10-min latency with those reported in experi-
mental studies under similar conditions (in vivo) [27–38] (in
the case of RFA experimental results of 12-min instead of
10min ablations, since this is much more common in clinical
practice). Despite the dispersion of the experimental results,
computer models in general are capable of providing values
within the ranges cited in the literature. As computational
models therefore come quite close to reproducing maximum
temperatures and coagulation volumes, it seems reasonable
to assume that the same can be said of the periablational
zones.
Our results show that extending ablation time from 5 to
10min can enlarge the coagulation zone during MWA but
not during RFA, a phenomenon that we have previously
seen in RFA simulations [14]. This is possibly due to the high
impedance of the desiccated tissue after roll-off. However, as
the electromagnetic power absorption in tissue during MWA
is not determined by the flow of electric current, power con-
tinues to be deposited even when the tissue near the
antenna has already become desiccated.
An interesting finding was that MWA and RFA create simi-
lar coagulation volumes at similar power levels. As far as we
know, only the study by Andreano et al. [39] compared RFA
and MWA at the same power level. Although they concluded
that MWA creates larger coagulations in an ex vivo setup,
their study was based only on the measurement of diame-
ters (4.37 vs. 3.39 cm). We also observed these differences of
diameters: 3.20 cm vs. 2.56 cm (lower values than in [39]
since we modeled an in vivo situation). As can be seen in
Figure 5, the differently shaped coagulation zones created by
both techniques suggest that the MWA transverse diameter
is larger but that the volumes are similar. In this regard, the
more spherical MWA coagulation zones could be considered
an advantage over the more elliptical RFA shapes.
The present results show that the commonly employed
RFA protocol (i.e., mean power 51W with impedance con-
trol) creates smaller periablational zones than MWA in a 10-
min ablation procedures (11.3 cm3 vs. 17.2 22.9 cm3 at
60 100W). Although this could mean a clear advantage of
RFA over MWA, when analyzing the periablational/coagula-
tion volume ratio, high-power MWA (100W) and short dur-
ation (5min) has the advantage of creating a larger
coagulation zone than RFA (19.5 vs. 16.3 cm3) and a smaller
periablational zone (10.9 vs. 11.3 cm3).
Our results show that the ability of 100W 5min MWA to
rapidly create relatively large coagulation zones seems to be
the key to simultaneously achieving large coagulation and
small periablational areas. This is in agreement with the
study by Cornelis et al. [40], who assessed the transition
Figure 4. Periablational/coagulation volume ratios in RFA/MWA simulations.
Lighter color bars and bottom values are the ratios computed just after switch-
off. Darker color bars represent the increased ratio 10min after switch-off.
Upper values show the ratio after this 10-min period.
INTERNATIONAL JOURNAL OF HYPERTHERMIA 1135
zone created after MWA, RFA, cryoablation and irreversible
electroporation in in vivo porcine kidney and liver, and
observed that 5min MWA created narrower transition zones
than other techniques. Their ‘transition zone’ is clearly
related to the ‘periablational zone’ since both zones are com-
prised of both viable and necrotic cells. Despite the promis-
ing benefits of using high-power and short-duration MWA,
other potentially important issues such as the risk of tumor
dissemination associated with high local pressure values
induced by high-power applications were not consid-
ered [41].
Our study was limited to comparing the volume of the
coagulation and periablational zones created with two com-
mercial devices, one for radiofrequency (RFA) and one for
microwave ablation (MWA). Although distant tumor growth
is probably affected by many different factors, the literature
suggests that reducing the amount of tumor cells subjected
to moderate hyperthermic heating, i.e., making the periabla-
tional zones as small as possible, could be beneficial [1]. In
this respect and although it is not possible to establish a
relationship with our computational results, the study by
Velez et al. [10] on a rat tumor model suggests that although
both MWA and RFA can increase distant tumor growth (i.e.,
large periablational areas), higher power and faster heating
protocols could potentially mitigate these undesirable
effects.
The main limitation of this study is its theoretical charac-
ter, since it is based on in silico models. Although the RFA
and MWA models used in this study were similar to other
experimentally validated models, and the data presented in
Table 2 suggests the validity of the models in terms of
predicting coagulation zone (CZ) size, reasonable doubts
could arise as to the models’ periablational zone (PZ) predic-
tion accuracy. To address this issue, we analyzed the experi-
mental data from a recent study on MWA that compared
simulated transient temperature profiles and ablation zones
in ex vivo bovine liver tissue vs. 3 D transient temperature
profiles and ablation zones measured by MRI thermometry
[42]. The analysis of this data (presented as Supplementary
material in the Appendix in the [42–44]) suggests a good
agreement between the PZ size estimated from computer
simulations and experimental measurements. Although the
analysis was done exclusively with MWA data, we think that
the validity can be extended to RFA since the thermal dam-
age process is governed by the same principles. Computer
modeling thus seems to be a suitable tool for studying
issues that would be challenging to accurately assess in
experiments, such as the relationship between the coagula-
tion zone and the periablational zone at different power lev-
els and times.
Another minor limitation was that we did not consider a
defined tumor region, which may have different thermal,
electrical, and perfusion characteristics relative to back-
ground liver. Although the present results should be consid-
ered as preliminary findings, they are the forerunners of
future clinical studies on quantifying the periablational and
coagulation zones during and after ablation by imaging tech-
niques to obtain thermal maps in real time [45,46].
Finally, only two commercial applicators were simulated,
which limits the conclusions to these models only. However,
as they are widely used in clinical practice and are consid-
ered to yield large ablation zone volumes, they are represen-
tative of optimal design in terms of maximizing coagulation
zone size. Different results would possibly be obtained with
other applicators specifically designed to minimize the peria-
blational zone volume.
5. Conclusions
Our study compared the size of the coagulation zone and
periablational zone created by two commercial devices, i.e.,
3-cm Cool-tip RF applicator vs. 14 G AMICA microwave
antenna. Since the periablational zone volume represents the
volume of cells subjected to moderate hyperthermic heating
it is desirable to maximize coagulation zone volume while
minimizing that of the periablational zone. Allowing for the
inherent limitations of a computational model, our results
suggest that for a 51W mean power 10min RFA with a 3-cm
Table 2. Comparison of RFA/MWA coagulation transverse diameters (in cm) computed by FEM (Finite Element Method) and reported in clinical
and experimental studies (in vivo ablations only) [27–38].
RFA
MWA
60 W 80 W 100 W
10min (FEM)
5min 10min 5min 10min 5min 10min12min (Clin/Exp)
FEM 2.56 2.73 3.20 3.06 3.33 3.43 3.78
Clin./
Exp.
1.8 [27], 1.85 [28]
2.0 [29], 2.6 [30,31]
2.54 [32]
2.2 [27]
3.14.1 [32]
3.1 [34]
2.35 [35]
3.12 [36]
3.5 [32]
2.37 [35]
3.8 [32]
2.85 [37]
3.4 [32]
3.3 [38]
4.9 [32]
Figure 5. Overlapping coagulation zones after 10min of RFA (51W) and
MWA (60W). Note that while the volumes offer similar values, the MWA trans-
verse diameter is larger.
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Cool-tip RF applicator, coagulation zone volumes could be
similar to those obtained by a 60W 10min MWA with a 14G
AMICA microwave antenna. Periablational zone volumes
could be larger for MWA than for RFA in all cases (5 and
10min durations, power levels of 60, 80 and 10W). High-
power short-duration MWA (100W and 5min) could provide
the lowest periablational/coagulation zone ratio, thus offer-
ing advantages over RFA in terms of creating larger coagula-
tion zones while keeping the periablational zone as small as
possible.
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